Alternative Prostate Treatments: Stent or Catheter for the Frail?

Garraway W M Collins G N Lee R J High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338: 469–471.

Lytton B Emery J M Howard B M The incidence of benign prostatic obstruction. Journal of Urology 1968;99: 639–645.

McKelvie G B Collins G N Hehir M Rogers A C N A study of benign prostatic hyperplasia — A challenge to British urology. British Journal of Urology 1993;71: 38–42.

Doll H A Black N A McPherson K Differences in outcome of transurethral resection of the prostate for benign prostatic hypertrophy between three diagnostic categories. British Journal of Urology 1993;72: 322–330.

Emberton M Neal D E Black N The national prostatectomy audit: the clinical management of patients during hospital admission.

Fabian K M Der intraprostatische ‘Partielle Katheter’. Urologe (A) 1980;19: 236–238.

Kirby R S Bishop M C Are the days of transurethral resection of prostate for benign prostatic hyperplasia numbered? British Medical Journal 1994;309: 716–718.

Talja M Tammela T Petas A Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of post-operative urinary retention after laser ablation of the prostate — Laser prostatectomy. Journal of Urology 1995;154: 2089–2092.

Dahlstrand C Grundtman S Pettersson S . The use of resorbable stent to avoid catheterisation after high energy TUMT for large, symptomatic, benign prostatic hyperplasia. Scandinavian Journal of Urology and Nephrology 1995 (suppl 1C9): 42.

Booth C M Al-Dabbagh M A Fowler C G A new prostatic stent with remarkable thermo-expandable properties. Minimally Invasive Therapy 19(32); 1 (suppl 1): 83.